These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 9655895

  • 1. The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations.
    Feldpausch DL, Needham LM, Stone MP, Althaus JS, Yamamoto BK, Svensson KA, Merchant KM.
    J Pharmacol Exp Ther; 1998 Jul; 286(1):497-508. PubMed ID: 9655895
    [Abstract] [Full Text] [Related]

  • 2. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
    Pierce RC, Kalivas PW.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
    [Abstract] [Full Text] [Related]

  • 3. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H, Sato H, Ida I, Oshima A, Sakurai N, Shihara N, Horikawa Y, Mikuni M.
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [Abstract] [Full Text] [Related]

  • 4. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats.
    Le Foll B, Diaz J, Sokoloff P.
    Synapse; 2003 Mar; 47(3):176-83. PubMed ID: 12494400
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.
    Merchant KM, Gill GS, Harris DW, Huff RM, Eaton MJ, Lookingland K, Lutzke BS, Mccall RB, Piercey MF, Schreur PJ, Sethy VH, Smith MW, Svensson KA, Tang AH, Vonvoigtlander PF, Tenbrink RE.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1392-403. PubMed ID: 8968364
    [Abstract] [Full Text] [Related]

  • 6. Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats.
    Meng ZH, Feldpaush DL, Merchant KM.
    Brain Res Mol Brain Res; 1998 Oct 30; 61(1-2):39-50. PubMed ID: 9795122
    [Abstract] [Full Text] [Related]

  • 7. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
    Mao L, Wang JQ.
    Synapse; 2001 Sep 01; 41(3):230-40. PubMed ID: 11418936
    [Abstract] [Full Text] [Related]

  • 8. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
    Giorgi O, Piras G, Lecca D, Corda MG.
    Neuroscience; 2005 Sep 01; 135(3):987-98. PubMed ID: 16154292
    [Abstract] [Full Text] [Related]

  • 9. Spatial and temporal profile of haloperidol-induced immediate-early gene expression and phosphoCREB binding in the dorsal and ventral striatum of amphetamine-sensitized rats.
    Hsieh HC, Li HY, Lin MY, Chiou YF, Lin SY, Wong CH, Chen JC.
    Synapse; 2002 Sep 15; 45(4):230-44. PubMed ID: 12125044
    [Abstract] [Full Text] [Related]

  • 10. Sensitization of amphetamine-induced stereotyped behaviors during the acute response.
    Kuczenski R, Segal DS.
    J Pharmacol Exp Ther; 1999 Feb 15; 288(2):699-709. PubMed ID: 9918578
    [Abstract] [Full Text] [Related]

  • 11. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
    Alttoa A, Eller M, Herm L, Rinken A, Harro J.
    Brain Res; 2007 Feb 02; 1131(1):138-48. PubMed ID: 17156751
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons.
    Tronci E, Simola N, Carta AR, De Luca MA, Morelli M.
    J Neurochem; 2006 Aug 02; 98(4):1078-89. PubMed ID: 16771831
    [Abstract] [Full Text] [Related]

  • 13. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
    Dietz DM, Tapocik J, Gaval-Cruz M, Kabbaj M.
    Physiol Behav; 2005 Oct 15; 86(3):347-55. PubMed ID: 16126238
    [Abstract] [Full Text] [Related]

  • 14. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice.
    Smith DG, Qi H, Svenningsson P, Wade M, Davis RJ, Gehlert DR, Nomikos GG.
    Synapse; 2008 Feb 15; 62(2):128-36. PubMed ID: 18000809
    [Abstract] [Full Text] [Related]

  • 15. Regional adaptations in PSD-95, NGFI-A and secretogranin gene transcripts related to vulnerability to behavioral sensitization to amphetamine in the Roman rat strains.
    Guitart-Masip M, Johansson B, Cañete T, Fernández-Teruel A, Tobeña A, Terenius L, Giménez-Llort L.
    Neuroscience; 2008 Jan 02; 151(1):195-208. PubMed ID: 18093743
    [Abstract] [Full Text] [Related]

  • 16. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD, Pierce RC.
    Neuroscience; 2006 Oct 13; 142(2):451-61. PubMed ID: 16844308
    [Abstract] [Full Text] [Related]

  • 17. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization.
    Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR.
    J Pharmacol Exp Ther; 1993 Jan 13; 264(1):249-55. PubMed ID: 8093727
    [Abstract] [Full Text] [Related]

  • 18. Injection of SCH 23390 into the ventral tegmental area blocks the development of neurochemical but not behavioral sensitization to cocaine.
    Steketee JD.
    Behav Pharmacol; 1998 Feb 13; 9(1):69-76. PubMed ID: 9832950
    [Abstract] [Full Text] [Related]

  • 19. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
    David HN, Ansseau M, Lemaire M, Abraini JH.
    Biol Psychiatry; 2006 Jul 01; 60(1):49-57. PubMed ID: 16427030
    [Abstract] [Full Text] [Related]

  • 20. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct 01; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.